Last reviewed · How we verify
NCT04678635
Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
NA trial testing Chronic transcranial direct current stimulation in Myopathy in 40 participants. Currently enrolling.
6 May 2024
Quick facts
| Lead sponsor | University of Sao Paulo |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 12 December 2020 |
| Primary completion | 6 May 2024 |
| Estimated completion | 4 December 2024 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Chronic transcranial direct current stimulation
Conditions studied
- Myopathy — all drugs for Myopathy →
Sponsor
University of Sao Paulo
Who can join
Adults 18 to 70, any sex, with Myopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Transcranial Direct Current Stimulation in Pain, Fatigue, and Health Quality of Life of Patients with Idiopathic Inflammatory Myopathies: A Randomized, Double-Blind, Sham-Controlled Crossover Clinical Trial.
Missé RG, Dos Santos AM, Borges IBP, Grecco MV, et al · · 2024 · cited 1× · PMID 38332984 · DOI 10.1155/2024/1583506
Verify or expand the search:
- PubMed search for NCT04678635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myopathy
Currently open trials in the same condition.
- NCT05599568 — Repeated Bout Effect i Neuromuscular Diseases · NA · recruiting
- NCT03749538 — Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies · NA · recruiting
- NCT06374719 — WiTNNess - TNNT1 Myopathy Natural History Study · recruiting
- NCT03660969 — Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease · active not recruiting
Other University of Sao Paulo trials
Trials by the same sponsor.
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
- NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04678635 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04678635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing